≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases (Event) * No. of Non- cases/Total N ** Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI/SE/SD ** P between groups *** P for trend ****
17301263 Tuohimaa 2007 prostate cancer 132 (total) 456 (total)
<40 nmol/L crude OR 1.93 1.19–3.13
40–59 (reference) 1
≥60 crude 1.32 0.69–2.56
<40 nmol/L adjusted OR 1.88 1.15–3.08
40–59 (reference) 1
≥60 adjusted 1.25 0.64–2.43

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: R-Z

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.